Search Results - "Shaver, Amy L"

Refine Results
  1. 1

    A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer by Shah, Yash B, Shaver, Amy L, Kelly, William Kevin, Lu-Yao, Grace

    Published in PloS one (29-08-2022)
    “…Abiraterone acetate and enzalutamide are commonly employed in prostate cancer therapy in an interchangeable manner. These drugs are highly efficacious in…”
    Get full text
    Journal Article
  2. 2

    A student-community partnership to enhance cancer research training by Melillo, Rebecca J, El Khoury, Christiane, Shaver, Amy L, Cunningham, Moriah, Benavides, Nathalia, Lacerda, Quezia, Kim, Felix J, Leader, Amy E

    Published in BMC medical education (17-10-2024)
    “…Despite the importance of community involvement in research, little formal training in community outreach and engagement (COE) is offered to cancer research…”
    Get full text
    Journal Article
  3. 3

    Effect of musculature on mortality, a retrospective cohort study by Shaver, Amy L, Platek, Mary E, Singh, Anurag K, Ma, Sung Jun, Farrugia, Mark, Wilding, Gregory, Ray, Andrew D, Ochs-Balcom, Heather M, Noyes, Katia

    Published in BMC cancer (22-06-2022)
    “…While often life-saving, treatment for head and neck cancer (HNC) can be debilitating resulting in unplanned hospitalization. Hospitalizations in cancer…”
    Get full text
    Journal Article
  4. 4

    Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocol by Shaver, Amy L, Nikita, Nikita, Sharma, Swapnil, Lefler, Daniel S, Basu-Mallick, Atrayee, Johnson, Jennifer M, Butryn, Meghan L, Lu-Yao, Grace

    Published in BMJ open (21-07-2022)
    “…IntroductionImmune checkpoint inhibitors (ICIs) have changed the treatment landscape for multiple cancer types. Sex plays an important role in both the…”
    Get full text
    Journal Article
  5. 5

    The association of the Affordable Care Act with nutrient consumption in adults in the United States by Kirk, Hilary, Tufuor, Theresa A, Shaver, Amy L, Nie, Jing, Devarshi, Prasad P, Marshall, Keri, Mitmesser, Susan Hazels, Noyes, Katia

    Published in Frontiers in public health (2023)
    “…The Patient Protection and Affordable Care Act, more commonly known as the ACA, was legislation passed in the United States in 2010 to expand access to health…”
    Get full text
    Journal Article
  6. 6

    Low-level exposure to lead, mercury, arsenic, and cadmium, and blood pressure among 8-17-year-old participants of the 2009–2016 National Health and Nutrition Examination Survey by Desai, Gauri, Niu, Zhongzheng, Luo, Wei, Frndak, Seth, Shaver, Amy L., Kordas, Katarzyna

    Published in Environmental research (01-06-2021)
    “…Dysregulation of systolic, diastolic blood pressure (SBP, DBP), and pulse pressure (PP) in children may predict elevated blood pressure (BP) in adulthood…”
    Get full text
    Journal Article
  7. 7

    Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs by Clark, Collin M., Shaver, Amy L., Aurelio, Leslie A., Feuerstein, Steven, Wahler, Robert G., Daly, Christopher J., Jacobs, David M.

    “…BACKGROUND/OBJECTIVES To examine the prevalence of potentially inappropriate medication (PIM) prescribing and its association with healthcare utilization and…”
    Get full text
    Journal Article
  8. 8

    A scoping review protocol to elucidate outcomes following abiraterone versus enzalutamide for prostate cancer by Yash B Shah, Amy L Shaver, William Kevin Kelly, Grace Lu-Yao

    Published in PloS one (29-08-2022)
    “…IntroductionAbiraterone acetate and enzalutamide are commonly employed in prostate cancer therapy in an interchangeable manner. These drugs are highly…”
    Get full text
    Journal Article
  9. 9

    Antibiotic prescribing for acute respiratory tract infections in the United States outpatient setting by Shaver, Amy L, Jacobs, David M, LaMonte, Michael J, Noyes, Katia

    Published in BMC family practice (02-07-2019)
    “…Acute respiratory tract infections (ARIs) are common in the outpatient setting. Although they are predominantly viral, antibiotics are often prescribed for the…”
    Get full text
    Journal Article
  10. 10

    Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States,1999–2017 by Shaver, Amy L., Clark, Collin M., Hejna, Mary, Feuerstein, Steven, Wahler, Robert G., Jacobs, David M.

    Published in Pharmacoepidemiology and drug safety (01-08-2021)
    “…Background Previous studies have demonstrated increasing mortality due to falls among older adults. The objective of this study was to determine whether there…”
    Get full text
    Journal Article
  11. 11

    Cross-sectional analysis of myosteatosis and physical function in pretreatment head and neck cancer patients by Shaver, Amy L., Noyes, Katia, Platek, Mary E., Singh, Anurag K., Erickson, Kayleigh, Wendel, Elizabeth, Wilding, Gregory, Ochs-Balcom, Heather M., Ray, Andrew

    Published in Supportive care in cancer (01-04-2022)
    “…Background Head and neck cancer (HNC) and its treatment are associated with muscle weakness and considerable long-term comorbidity. The goal of this study was…”
    Get full text
    Journal Article
  12. 12

    Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors by Shaver, Amy L, Tufuor, Theresa A, Nie, Jing, Ekimura, Shauna, Marshall, Keri, Mitmesser, Susan Hazels, Noyes, Katia

    Published in Cancers (14-12-2021)
    “…Cancer patients are at risk for malnutrition; the aim of this study was to provide a cost-effectiveness analysis of dietary supplementation in cancer…”
    Get full text
    Journal Article
  13. 13

    The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review by Shaver, Amy L, Sharma, Swapnil, Nikita, Nikita, Lefler, Daniel S, Basu-Mallick, Atrayee, Johnson, Jennifer M, Butryn, Meghan, Lu-Yao, Grace

    Published in Cancers (18-12-2021)
    “…Cancer therapies are associated with multiple adverse effects, including (but not limited to) cancer-related fatigue (CRF). Fatigue is one of the most common…”
    Get full text
    Journal Article
  14. 14

    Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review by Shah, Yash B, Shaver, Amy L, Beiriger, Jacob, Mehta, Sagar, Nikita, Nikita, Kelly, William Kevin, Freedland, Stephen J, Lu-Yao, Grace

    Published in Cancers (03-08-2022)
    “…Abiraterone acetate (AA) and enzalutamide (ENZ) are commonly used for metastatic prostate cancer. It is unclear how their outcomes and toxicities vary with…”
    Get full text
    Journal Article
  15. 15

    A Retrospective Cohort Study of Myosteatosis and Quality of Life in Head and Neck Cancer Patients by Shaver, Amy L, Noyes, Katia, Ochs-Balcom, Heather M, Wilding, Gregory, Ray, Andrew D, Ma, Sung Jun, Farrugia, Mark, Singh, Anurag K, Platek, Mary E

    Published in Cancers (25-08-2021)
    “…Head and neck cancer (HNC) treatment-related morbidity can be detrimental to quality of life (QOL). Myosteatosis is associated with poor QOL in multiple…”
    Get full text
    Journal Article
  16. 16

    Racial differences in the utilization of MRI-guided biopsy before prostate cancer diagnosis by Lu-Yao, Grace L., Gandhi, Krupa, Nikita, Nikita, Shaver, Amy L, Sharma, Swapnil, Keith, Scott W., Freedland, Stephen J.

    Published in Journal of clinical oncology (01-06-2023)
    “…5093 Background: Most low-risk prostate cancer (PCa) patients undergo active surveillance (AS). Compared with Whites, Blacks are more likely to opt for AS and…”
    Get full text
    Journal Article
  17. 17

    Enzalutamide vs abiraterone in patients with prostate cancer with and without type 2 diabetes mellitus by Shaver, Amy L, Nikita, Nikita, Gandhi, Krupa, Sharma, Swapnil, Keith, Scott W., Yang, Christopher C., Lu-Yao, Grace L.

    Published in Journal of clinical oncology (01-06-2023)
    “…5066 Background: Estimations are that 8-18% of newly diagnosed cancer patients have Type 2 Diabetes Mellitus (T2DM). Current guidelines offer no clarification…”
    Get full text
    Journal Article
  18. 18

    Differences in concomitant medication prescribing before and after novel hormonal therapy (NHT) in men with prostate cancer: A population-based study by Yang, Amy, Mei, Chuchu, Banks, Joshua, Nikita, Nikita, Shaver, Amy L, Keith, Scott W., Lu-Yao, Grace L.

    Published in Journal of clinical oncology (20-02-2023)
    “…138 Background: Prostate cancer (PCa) is the most common non-skin cancer affecting American men. Two common NHTs used to treat PCa are enzalutamide and…”
    Get full text
    Journal Article
  19. 19

    Medication use among lung cancer patients before and after initiating immune checkpoint inhibitors: A population study by Mei, Chuchu, Yang, Amy, Shaver, Amy L, Nikita, Nikita, Banks, Joshua, Keith, Scott W., Lu-Yao, Grace L.

    Published in Journal of clinical oncology (01-06-2022)
    “…e21119 Background: Polypharmacy is an independent prognostic factor in older patients with lung cancer treated with immune checkpoint inhibitors (ICIs)…”
    Get full text
    Journal Article
  20. 20

    Assessing the willingness to participate in future clinical trials by Shaver, Amy L., Nikita, Nikita, Banks, Joshua, El Khoury, Christiane, Melillo, Rebecca J., Song, Yawei, Lu-Yao, Grace L., Leader, Amy

    Published in Journal of clinical oncology (01-06-2023)
    “…e18899 Background: Sidney Kimmel Cancer Center at Jefferson in Philadelphia, PA conducts a bi-annual survey to identify and describe their catchment area…”
    Get full text
    Journal Article